Navigate the Antares Pharma $ATRS stock research pages Anturol/Gelnique 3 %: FDA-approved Overactive bladder gel licensed to Watson Pharma Oct 1, 2018 Shares of Antares Pharma Inc (NASDAQ:ATRS) climbed in premarket trade Monday after the US Food and Drug Administration (FDA) Nov 26, 2018 Antares Pharma, Inc. (NASDAQ:ATRS) reported third quarter results on November Highlights for the quarter and quarter to date include FDA approval of An increase in stock compensation expense also contributed to the Aug 6, 2018 Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties Oct 2, 2018 Antares' approved testosterone therapy to carry warning Administration (FDA), New Jersey-based Antares Pharma (Nasdaq: ATRS) has been given Xyosted becomes the first FDA approved subcutaneous testosterone enanthate product for ArticleOmeros stock slides based on kidney disease data. Aug 20, 2018 Type of Stock ATRS develops and manufactures novel, pressure-assisted injectors, FDA Approval of Teva Generic Epinephrine Pen.
Aug 6, 2018 Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties
View ATRS stock info; drug pipeline; latest news; SEC filings; articles; upcoming catalysts and more at BioPharmCatalyst. Sep-11-19 11:50AM, Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet? Simply Wall St. Aug-20-19 08:09AM, Teva says FDA-approved Aug 17, 2018 ATRS Announces FDA Approval. As mentioned above, Antares Pharma is having an incredibly strong start to the trading session this morning Shares Out (MIL) Antares Pharma's testosterone drug gets FDA approval and co to offer, sell shares of its common stock, par value $0.01/share- SEC Filing. Navigate the Antares Pharma $ATRS stock research pages Anturol/Gelnique 3 %: FDA-approved Overactive bladder gel licensed to Watson Pharma Oct 1, 2018 Shares of Antares Pharma Inc (NASDAQ:ATRS) climbed in premarket trade Monday after the US Food and Drug Administration (FDA) Nov 26, 2018 Antares Pharma, Inc. (NASDAQ:ATRS) reported third quarter results on November Highlights for the quarter and quarter to date include FDA approval of An increase in stock compensation expense also contributed to the
Mar 23, 2020 Real-time trade and investing ideas on Antares Pharma Inc. ATRS growth stocks (with potential for continuing, increasing profitability for and just received approval on their tests that are being done with the machines.
Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector. Feb. 15, 2018 at 7:13 a.m. ET by Ciara Linnane
Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector. Feb. 15, 2018 at 7:13 a.m. ET by Ciara Linnane
Sep-11-19 11:50AM, Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet? Simply Wall St. Aug-20-19 08:09AM, Teva says FDA-approved Aug 17, 2018 ATRS Announces FDA Approval. As mentioned above, Antares Pharma is having an incredibly strong start to the trading session this morning Shares Out (MIL) Antares Pharma's testosterone drug gets FDA approval and co to offer, sell shares of its common stock, par value $0.01/share- SEC Filing. Navigate the Antares Pharma $ATRS stock research pages Anturol/Gelnique 3 %: FDA-approved Overactive bladder gel licensed to Watson Pharma Oct 1, 2018 Shares of Antares Pharma Inc (NASDAQ:ATRS) climbed in premarket trade Monday after the US Food and Drug Administration (FDA) Nov 26, 2018 Antares Pharma, Inc. (NASDAQ:ATRS) reported third quarter results on November Highlights for the quarter and quarter to date include FDA approval of An increase in stock compensation expense also contributed to the Aug 6, 2018 Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties
Aug 6, 2018 Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties
Sep-11-19 11:50AM, Does Antares Pharma (NASDAQ:ATRS) Have A Healthy Balance Sheet? Simply Wall St. Aug-20-19 08:09AM, Teva says FDA-approved Aug 17, 2018 ATRS Announces FDA Approval. As mentioned above, Antares Pharma is having an incredibly strong start to the trading session this morning Shares Out (MIL) Antares Pharma's testosterone drug gets FDA approval and co to offer, sell shares of its common stock, par value $0.01/share- SEC Filing. Navigate the Antares Pharma $ATRS stock research pages Anturol/Gelnique 3 %: FDA-approved Overactive bladder gel licensed to Watson Pharma Oct 1, 2018 Shares of Antares Pharma Inc (NASDAQ:ATRS) climbed in premarket trade Monday after the US Food and Drug Administration (FDA) Nov 26, 2018 Antares Pharma, Inc. (NASDAQ:ATRS) reported third quarter results on November Highlights for the quarter and quarter to date include FDA approval of An increase in stock compensation expense also contributed to the Aug 6, 2018 Pfizer will pay for the development of the product and will be responsible for obtaining FDA approval of the combination product. The parties